133 related articles for article (PubMed ID: 6233044)
1. Effects of the antiandrogen, cyproterone acetate, on the induction of papillomas, DNA synthesis and ornithine decarboxylase activity in mouse skin.
Davidson KA; Ewald L; Herrmann A; Ogle SP; Slaga TJ
Carcinogenesis; 1984 May; 5(5):609-14. PubMed ID: 6233044
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and tumor promotion by N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) in mouse skin.
Nakadate T; Yamamoto S; Aizu E; Kato R
Pharmacology; 1986; 32(3):167-75. PubMed ID: 3083437
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R
Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
6. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate.
Smart RC; Huang MT; Han ZT; Kaplan MC; Focella A; Conney AH
Cancer Res; 1987 Dec; 47(24 Pt 1):6633-8. PubMed ID: 3677097
[TBL] [Abstract][Full Text] [Related]
8. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
[TBL] [Abstract][Full Text] [Related]
9. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse skin tumor promotion by adriamycin and daunomycin in combination with verapamil or palmitoylcarnitine.
Satyamoorthy K; Perchellet JP
Cancer Lett; 1990 Dec; 55(2):135-42. PubMed ID: 2265412
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.
Nesnow S; Bergman H; Slaga TJ
Environ Health Perspect; 1986 Sep; 68():19-25. PubMed ID: 3780628
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of sn-1,2-didecanoylglycerol and 12-O-tetradecanoylphorbol-13-acetate on cutaneous morphology, inflammation and tumor promotion in CD-1 mice.
Smart RC; Huang MT; Monteiro-Riviere NA; Wong CQ; Mills KJ; Conney AH
Carcinogenesis; 1988 Dec; 9(12):2221-6. PubMed ID: 3191568
[TBL] [Abstract][Full Text] [Related]
13. Cepharanthine inhibits two-stage tumor promotion by 12-O-tetradecanoylphorbol 13-acetate and mezerein on skin tumor formation in mice initiated with 7,12-dimethylbenz[a]anthracene.
Yasukawa K; Takido M; Takeuchi M; Akasu M; Nakagawa S
J Cancer Res Clin Oncol; 1991; 117(5):421-4. PubMed ID: 1909698
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice.
Wei H; Tye L; Bresnick E; Birt DF
Cancer Res; 1990 Feb; 50(3):499-502. PubMed ID: 2105157
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mouse skin tumor promotion by dietary 13-cis-retinoic acid and alpha-difluoromethylornithine.
Verma AK; Duvick L; Ali M
Carcinogenesis; 1986 Jun; 7(6):1019-23. PubMed ID: 3085964
[TBL] [Abstract][Full Text] [Related]
17. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
Ordman AB; Cleaveland JS; Boutwell RK
Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
[TBL] [Abstract][Full Text] [Related]
18. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
Verma AK
Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
[TBL] [Abstract][Full Text] [Related]
19. Modulation of chrysarobin skin tumor promotion.
DiGiovanni J; Kruszewski FH; Chenicek KJ
Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
[TBL] [Abstract][Full Text] [Related]
20. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
Kruszewski FH; Chenicek KJ; Digiovanni J
Cancer Lett; 1986 Sep; 32(3):263-9. PubMed ID: 3768852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
